×
About 407 results

ALLMedicine™ Evans Syndrome Center

Research & Reviews  203 results

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the devel...
https://doi.org/10.1016/j.thromres.2021.02.021
Thrombosis Research; Diez-Feijóo R, Rodríguez-Sevilla JJ et. al.

Mar 14th, 2021 - Long-term safety and efficacy of eltrombopag in adults with persitent/chronic primary immune thrombocytopenia (ITP) evaluated in EXTEND study, showed a high response rate (80%) but, in the clinical safety study, it was observed that 6% of the pati...

Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic i...
https://doi.org/10.1111/ejh.13600
European Journal of Haematology; Grimes AB, Kim TO et. al.

Feb 11th, 2021 - Evans syndrome is a rare but challenging disorder in children; and despite rapidly growing evidence for targetable systemic immune dysregulation driving these "idiopathic" autoimmune cytopenias, precision diagnosis and management remains sub-optim...

Evans syndrome and infections: a dangerous cocktail to manage with caution.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850928
Blood Transfusion = Trasfusione Del Sangue; Fattizzo B

Feb 1st, 2021 - Evans syndrome and infections: a dangerous cocktail to manage with caution.|2021|Fattizzo B,|

ADA2 deficiency (DADA2) associated with Evans Syndrome and a severe ADA2 genotype.
https://doi.org/10.1093/rheumatology/keab011
Rheumatology (Oxford, England); Ferriani MPL, Valera ET et. al.

Jan 25th, 2021 - ADA2 deficiency (DADA2) associated with Evans Syndrome and a severe ADA2 genotype.|2021|Ferriani MPL,Valera ET,de Sousa GR,Sandrin-Garcia P,de Moura RR,|

Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifes...
https://doi.org/10.3324/haematol.2020.271106
Haematologica Pincez T, Fernandes H et. al.

Jan 14th, 2021 - Pediatric-onset Evans syndrome (pES) is defined by both immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA) before the age of 18 years. There have been no comprehensive long-term studies of this rare disease, which can be ...

see more →

Clinicaltrials.gov  203 results

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the devel...
https://doi.org/10.1016/j.thromres.2021.02.021
Thrombosis Research; Diez-Feijóo R, Rodríguez-Sevilla JJ et. al.

Mar 14th, 2021 - Long-term safety and efficacy of eltrombopag in adults with persitent/chronic primary immune thrombocytopenia (ITP) evaluated in EXTEND study, showed a high response rate (80%) but, in the clinical safety study, it was observed that 6% of the pati...

Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic i...
https://doi.org/10.1111/ejh.13600
European Journal of Haematology; Grimes AB, Kim TO et. al.

Feb 11th, 2021 - Evans syndrome is a rare but challenging disorder in children; and despite rapidly growing evidence for targetable systemic immune dysregulation driving these "idiopathic" autoimmune cytopenias, precision diagnosis and management remains sub-optim...

Evans syndrome and infections: a dangerous cocktail to manage with caution.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850928
Blood Transfusion = Trasfusione Del Sangue; Fattizzo B

Feb 1st, 2021 - Evans syndrome and infections: a dangerous cocktail to manage with caution.|2021|Fattizzo B,|

ADA2 deficiency (DADA2) associated with Evans Syndrome and a severe ADA2 genotype.
https://doi.org/10.1093/rheumatology/keab011
Rheumatology (Oxford, England); Ferriani MPL, Valera ET et. al.

Jan 25th, 2021 - ADA2 deficiency (DADA2) associated with Evans Syndrome and a severe ADA2 genotype.|2021|Ferriani MPL,Valera ET,de Sousa GR,Sandrin-Garcia P,de Moura RR,|

Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifes...
https://doi.org/10.3324/haematol.2020.271106
Haematologica Pincez T, Fernandes H et. al.

Jan 14th, 2021 - Pediatric-onset Evans syndrome (pES) is defined by both immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA) before the age of 18 years. There have been no comprehensive long-term studies of this rare disease, which can be ...

see more →